hotspot -WSS

hotspot

author：comprehensive 2025-09-30 00:38:32 - browse：196

People in business and medical wardrobe in a table discussion — coverage from STAT — Adobe

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： House panel to mark up pandemic

WSS

Roche subsidiary Foundation Medicine opens new headquarters

Vertex Pharmaceuticals may move headquarters in Boston

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

focus

hotspot

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

Neutralizing antibodies against HIV shows promise in children

ChatGPT in medicine: STAT answers readers' burning questions

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

How to save PrEP access — and even expand it

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

Hepatitis C has a cure — but many Americans still lack access to it

FDA's naming rule on biosimilars has undermined competition

Medical leaders decry Supreme Court decision on affirmative action

Trump seeks lengthy delay of classified docs trial, citing upcoming election

explore

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Scientists boost immune system in aging mice by making it youthful

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

With fresh data, a dynamic duo powers Eli Lilly to new heights

Roche subsidiary Foundation Medicine opens new headquarters

FDA approves Leqembi, a milestone in Alzheimer’s treatment

hotspot

focus

knowledge

hotspot